How i treat postpartum hemorrhage

Blood

Volumn 125, Issue 18, 2015, Pages 2759-2770

  Pavord, Sue ^a,b   Maybury, Helena ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CARBOPROST; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; OXIDIZED REGENERATED CELLULOSE; OXYTOCIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; UTEROTONIC AGENT;

ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD EXAMINATION; BLOOD TRANSFUSION; CLINICAL ASSESSMENT; CRYOPRECIPITATE; DISEASE EXACERBATION; ERYTHROCYTE CONCENTRATE; HIGH RISK PREGNANCY; HUMAN; INTERNAL ILIAC ARTERY; INTERNATIONAL NORMALIZED RATIO; INTERVENTIONAL RADIOLOGY; LIGATION; MATERNAL CARE; MATERNAL MORTALITY; MORBIDITY; OBSTETRIC HEMORRHAGE; POINT OF CARE TESTING; POSTPARTUM HEMORRHAGE; PRENATAL CARE; PRIORITY JOURNAL; PROTHROMBIN TIME; STAFF TRAINING; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; THROMBOELASTOMETRY; UTERINE ARTERY; UTERUS BLOOD FLOW; ADULT; ADVERSE EFFECTS; BLOOD FLOW; CASE REPORT; DELIVERY; FEMALE; PATHOLOGY; PREGNANCY; UTERUS; VASCULARIZATION;

ADULT; DELIVERY, OBSTETRIC; FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; REGIONAL BLOOD FLOW; UTERUS;

EID: 84929458946     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-10-512608     Document Type: Article

References (84)

1. Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. Green-top Guideline. No. 52. 2009.
2. Health & Social Care Information Centre. Health Survey for England 2015. Available at: www.hscic.gov.uk/catalogue/PUB13218/HSE2012-Sum-bklet.pdf. Accessed February 2015.
3. Kramer MS, Berg C, Abenhaim H, et al. Incidence, risk factors, and temporal trends in severe postpartum haemorrhage. Am J Obstet Gynecol. 2013; 209(5): 449.e1-449.e7.
4. Marr L, Lennox C, McFadyen AK. Quantifying severe maternal morbidity in Scotland: a continuous audit since 2003. Curr Opin Anaesthesiol. 2014;27(3):275-281.
5. Paterson-Brown S, Bamber J; on behalf of the MBRRACE-UK Haemorrhage Chapter Writing Group. Prevention and treatment of haemorrhage. In: Knight M, Kenyon S, Brocklehurst P, Neilson J, Shakespeare J, Kurinczuk JJ, eds. on behalf of MBRRACE-UK. Saving Lives, Improving Mothers' Care-Lessons Learned to Inform Future Maternity Care From the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-12. Oxford, UK: National Perinatal Epidemiology Unit, University of Oxford; 2014: 45-55.
6. World Health Organisation. Maternal mortality: Fact Sheet 348. Available at: www.who.int/mediacentre/factsheets/fs348/en. Accessed May 2014.
7. Dildy GA III, Paine AR, George NC, Velasco C. Estimating blood loss: can teaching significantly improve visual estimation? Obstet Gynecol. 2004; 104(3):601-606.
8. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG. 2006;113(8):919-924.
9. Maslovitz S, Barkai G, Lessing JB, Ziv A, Many A. Improved accuracy of postpartum blood loss estimation as assessed by simulation. Acta Obstet Gynecol Scand. 2008;87(9):929-934.
10. Toledo P, Paloma MD, Eosakul ST, et al. Decay in blood loss estimation skills after web-based didactic training simulation in healthcare. J Soc Simulation Healthcare. 2012;7(1):18-21.
11. Prendiville WJP, Elbourne D, McDonald SJ. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev. 2000;3.
12. Roberts CL, Lain SJ, Morris JM. Variation in adherence to recommendations for management of the third stage of labor. Int J Gynaecol Obstet. 2008;103(2):172-173.
13. Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev. 2014;2:CD003249.
14. McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev. 2004;(1):CD000201.
15. Buttino L Jr, Garite TJ. The use of 15 methyl F2 alpha prostaglandin (Prostin 15M) for the control of postpartum hemorrhage. Am J Perinatol. 1986; 3(3):241-243.
16. Oleen MA, Mariano JP. Controlling refractory atonic postpartum hemorrhage with Hemabate sterile solution. Am J Obstet Gynecol. 1990; 162(1):205-208.
17. Al-Sawaf A, El-Mazny A, Shohayeb A. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage. J Obstet Gynaecol. 2013;33(3):277-279.
18. Derman RJ, Kodkany BS, Goudar SS, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet. 2006; 368(9543):1248-1253.
19. Winikoff B, Dabash R, Durocher J, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet. 2010;375(9710):210-216.
20. Gibbins KJ, Albright CM, Rouse DJ. Postpartum hemorrhage in the developed world: whither misoprostol? Am J Obstet Gynecol. 2013;208(3): 181-183.
21. NICE Interventional Procedures Guidance [IPG144]. Intraoperative blood cell salvage in obstetrics. 2005. Available at: www.nice.org.uk/Guidance/IPG144. Accessed December 2014.
22. Sullivan JV, Crouch ME, Stocken G, Lindow SW. Blood cell salvage during cesarean delivery. Int J Gynaecol Obstet. 2011;115(2):161-163.
23. Rebarber A, Lonser R, Jackson S, Copel JA, Sipes S. The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol. 1998; 179(3 Pt 1):715-720.
24. Huissoud C, Carrabin N, Audibert F, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG. 2009;116(8):1097-1102.
25. Charbit B, Mandelbrot L, Samain E, et al; PPH Study Group. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007;5(2): 266-273.
26. de Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth. 2011;20(2): 135-141.
27. Orlikowski CE, Rocke DA. Coagulation monitoring in the obstetric patient. Int Anesthesiol Clin. 1994; 32(2):173-191.
28. Wong CA, Liu S, Glassenberg R. Comparison of thrombelastography with common coagulation tests in preeclamptic and healthy parturients. Reg Anesth. 1995;20(6):521-527.
29. Macafee B, Campbell JP, Ashpole K, et al. Reference ranges for thromboelastography (TEG (®)) and traditional coagulation tests in term parturients undergoing caesarean section under spinal anaesthesia. Anaesthesia. 2012;67(7): 741-747.
30. Maybury HJ, Waugh J, Gornall A, Pavord S. There is a return to non-pregnant coagulation parameters after four not six weeks postpartum following spontaneous vaginal delivery. Obstetric Medicine. 2009;1:92-94.
31. Maybury HJ, Gornall AG, Kurinczuk J, Konje JC, Pavord S. The use of thromboelastography to assess haemostatic changes in postpartum women. J Obstet Gynaecol. 2004;24(suppl 1): S35-S36.
32. Steer PL, Finley BE, Blumenthal LA. Abruptio placentae and disseminated intravascular coagulation: use of thrombelastography and sonoclot analysis. Int J Obstet Anesth. 1994;3(4): 229-233.
33. Sharma SK, Vera RL, Stegall WC, Whitten CW. Management of a postpartum coagulopathy using thrombelastography. J Clin Anesth. 1997;9(3): 243-247.
34. Girdauskas E, Kempfert J, Kuntze T, et al. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. J Thorac Cardiovasc Surg. 2010;140(5):1117-1124.
35. Ak K, Isbir CS, Tetik S, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg. 2009;24(4):404-410.
36. Holcomb JB, Minei KM, Scerbo ML, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg. 2012;256(3):476-486.
37. Arash A, Wikkelso S, Brok J, et al; Cochrane Anaesthesia Group. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Sys Rev. 2011:CD007871.
38. Oudghiri M, Keita H, Kouamou E, et al. Reference values for rotation thromboelastometry (ROTEM®) parameters following non-haemorrhagic deliveries. Correlations with standard haemostasis parameters. Thromb Haemost. 2011;106(1):176-178.
39. Polak F, Kolnikova I, Lips M, Parizek A, Blaha J, Stritesky M. New recommendations for thromboelastography reference ranges for pregnant women. Thromb Res. 2011;128(4): e14-e17.
40. Simon L, Santi TM, Sacquin P, Hamza J. Pre-anaesthetic assessment of coagulation abnormalities in obstetric patients: usefulness, timing and clinical implications. Br J Anaesth. 1997;78(6):678-683.
41. Gayat E, Resche-Rigon M, Morel O, et al. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med. 2011; 37(11):1816-1825.
42. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012;108(6): 984-989.
43. Collins PW, Lilley G, Bruynseels D, et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood. 2014; 124(11):1727-1736.
44. Gün I, Ozdamar O, Ertugrul S, Oner O, Atay V. The effect of placental removal method on perioperative hemorrhage at cesarean delivery; a randomized clinical trial. Arch Gynecol Obstet. 2013;288(3):563-567.
45. Heesen M, Hofmann T, Klöhr S, et al. Is general anaesthesia for caesarean section associated with postpartum haemorrhage? Systematic review and meta-analysis. Acta Anaesthesiol Scand. 2013;57(9):1092-1102.
46. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30(6): 270-382.
47. Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ; British Committee for Standards in Haematology. Guidelines on the management of massive blood loss. Br J Haematol. 2006;135(5): 634-641.
48. Thomas D, Wee M, Clyburn P, et al; Association of Anaesthetists of Great Britain and Ireland. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia. 2010;65(11):1153-1161.
49. Szecsi PB, Jørgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S. Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010; 103(4):718-727.
50. Liu XH, Jiang YM, Shi H, Yue XA, Wang YF, Yang H. Prospective, sequential, longitudinal study of coagulation changes during pregnancy in Chinese women. Int J Gynaecol Obstet. 2009;105(3): 240-243.
51. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth. 2009;102(6):793-799.
52. De Lloyd L, Collins PW, Kaye A, Collis RE. Early fibrinogen as a predictor of red cell requirements during postpartum haemorrhage. Int J Obstet Anesth. 2012;21:S13.
53. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sørensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth. 2008;101(6):769-773.
54. Ahmed S, Harrity C, Johnson S, et al. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage-an observational study. Transfus Med. 2012;22(5):344-349.
55. Bell SF, Rayment R, Collins PW, Collis RE. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth. 2010;19(2): 218-223.
56. Glover NJ, Collis RE, Collins P. Fibrinogen concentrate use during major obstetric haemorrhage. Anaesthesia. 2010;65(12): 1229-1230.
57. Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia. 2015; 70(2):166-175.
58. Wikkelsø AJ, Edwards HM, Afshari A, et al; FIB-PPH trial group. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth. 2015;aeu444.
59. Collins PW. Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: Obstetrics Bleeding Study 2. Available at: www.controlled-trials.com/ISRTCN46295339/Fibrinogen. Accessed December 2014.
60. Xu J, Gao W, Ju Y. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial. Arch Gynecol Obstet. 2013;287(3):463-468.
61. Ducloy-Bouthors AS, Jude B, Duhamel A, et al; EXADELI Study Group. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011;15(2):R117.
62. Goswami U, Sarangi S, Gupta S, Babbar S. Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: A double-blind randomized case control prospective trial. Saudi J Anaesth. 2013;7(4):427-431.
63. Clinicaltrials.gov. World maternal Antifibrinolytic Trial (WOMAN). NCT00872469. Available at: www.trialsjournal.com/content/11/1/40. Accessed December 2014.
64. Quigley J, Byrne J, Diaz M, et al. Use of recombinant factor VIIa (rFVIIa) in acute life threatening primary postpartum haemorrhage: A case report. Vox Sang. 2013;105:272-273.
65. Alfirevic Z, Elbourne D, Pavord S, et al. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. Obstet Gynecol. 2007;110(6): 1270-1278.
66. Franchini M, Franchi M, Bergamini V, et al. The use of recombinant activated FVII in postpartum hemorrhage. Clin Obstet Gynecol. 2010;53(1): 219-227.
67. Lavigne-Lissalde G, Aya G, Mercier F, et al. Recombinant human FVIIa for reducing the need of invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial [published online ahead of print March 11, 2015]. J Thromb Haemostas. doi:10.1111/jth.12844.
68. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv. 2007;62(8):540-547.
69. Lu MC, Korst LM, Fridman M, Muthengi E, Gregory KD. Identifying women most likely to benefit from prevention strategies for postpartum hemorrhage. J Perinatol. 2009;29(6):422-427.
70. Wetta LA, Szychowski JM, Seals S, et al. Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery. Am J Obstet Gynecol. 2013;209(1):51.e1-51.e6.
71. Giannella L, Mfuta K, Pedroni D, et al. Delays in the delivery room of a primary maternity unit: a retrospective analysis of obstetric outcomes. J Matern Fetal Neonatal Med. 2013;26(6): 593-597.
72. Fawcus S, Moodley J. Postpartum haemorrhage associated with caesarean section and caesarean hysterectomy. Best Pract Res Clin Obstet Gynaecol. 2013;27(2):233-249.
73. Kadir RA, Davies J, Winikoff R, et al. Pregnancy complications and obstetric care in women with inherited bleeding disorders. Haemophilia. 2013; 19(suppl 4):1-10.
74. Lee CA, Chi C, Pavord SR, et al; UK Haemophilia Centre Doctors' Organization. The obstetric and gynaecological management of women with inherited bleeding disorders-review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia. 2006;12(4):301-336.
75. Baumann Kreuziger LM, Morton CT, Reding MT. Is prophylaxis required for delivery in women with factor VII deficiency? Haemophilia. 2013;19(6): 827-832.
76. Mensah PK, Oppenheimer C, Watson C, Pavord S. Congenital afibrinogenaemia in pregnancy. Haemophilia. 2011;17(1):167-168.
77. Mumford AD, Ackroyd S, Alikhan R, et al; BCSH Committee. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2014;167(3):304-326.
78. Akkad A, Oppenheimer C, Mushambi M, Pavord S. Intrapartum care for women on full anticoagulation. Int J Obstet Anesth. 2003;12(3): 188-192.
79. Pavord S, Myers B, Robinson S, Allard S, Strong J, Oppenheimer C. British Committee for Standards in Haematology. UK guidelines on the management of iron deficiency in pregnancy. Br J Haem. 2012;156(5):588-600.
80. So-Osman C, Cicilia J, Brand A, Schipperus M, Berning B, Scherjon S. Triggers and appropriateness of red blood cell transfusions in the postpartum patient-a retrospective audit. Vox Sang. 2010;98(1):65-69.
81. Parker J, Thompson J, Stanworth S. A retrospective one-year single-centre survey of obstetric red cell transfusions. Int J Obstet Anesth. 2009;18(4):309-313.
82. RCOG. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-top Guideline. 37a. 2009.
83. Doumouchtsis SK, Nikolopoulos K, Talaulikar V, Krishna A, Arulkumaran S. Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review. BJOG. 2014;121(4):382-388.
84. Gizzo S, Saccardi C, Patrelli TS, et al. Fertility rate and subsequent pregnancy outcomes after conservative surgical techniques in postpartum hemorrhage: 15 years of literature. Fertil Steril. 2013;99(7):2097-2107.